Abstract
The 5β-cholestane-3α,7α-diol 26-hydroxylase system, which is involved in the conversion of cholesterol to chenodeoxycholic acid, was studied in rat liver mitochondria. 26-Hydroxylase of 5β-cholestane-3α,7α-diol showed the following characteristics. (i) 5β-Cholestane-3α,7α-diol 26-hydroxylase requires electron donors similar to those required for 5β-cholestane-3α,7α,12α-triol 26-hydroxylase. (ii) Both enzyme activities are inhibited by similar inhibitors such as carbon monoxide and phenylisocyanide, but not by respiratory inhibitors such as rotenone, amytal, antimycin A, and cyanide. (iii) The presence of 5β-cholestane-3α,7α-12α-triol in the incubation mixture for 5β-cholestane-3α,7α-diol inhibits the latter activity in a competitive manner. (iv) The distribution patterns of both enzyme activities in submitochondrial fractions are similar. (v) The reconstituted enzyme system composed of partially purified cytochrome P-450 from rat liver mitochondrial inner membrane, NADPH-adrenodoxin reductase and adrenodoxin (both purified from bovine adrenocortical mitochondria), and NADPH showed 26-hydroxylation activity not only for 5β-cholestane-3α,7α-diol but also for 5β-cholestane-3α,7α,12α-triol; both activities were comparable.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
